Filtered By:
Source: J Formos Med Assoc
Condition: Thrombosis
Procedure: Kidney Transplant
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Erythropoiesis-stimulating agents in chronic kidney disease: What have we learned in 25 years?
Abstract
Since the pioneering studies by Eschbach et al in 1987, erythropoiesis-stimulating agents (ESAs) have become the mainstay of anemia therapy in chronic kidney disease (CKD) patients. The introduction of ESAs 25 years ago markedly improved the lives of many patients with CKD, who until then had severe, often transfusion-dependent anemia. However, randomized controlled trials demonstrate an increased risk for cardiovascular events such as stroke, thrombosis, and death at nearly normal hemoglobin concentrations and higher ESA doses in CKD. By contrast, kidney transplant recipients may represent a unique popu...
Source: J Formos Med Assoc - September 30, 2013 Category: Journals (General) Authors: Hung SC, Lin YP, Tarng DC Tags: J Formos Med Assoc Source Type: research
